InvestorsHub Logo
Followers 14
Posts 2860
Boards Moderated 0
Alias Born 12/23/2014

Re: None

Monday, 12/11/2017 10:04:11 AM

Monday, December 11, 2017 10:04:11 AM

Post# of 2463
REPR is introducing their infusion system to big pharma in new and ongoing
chemotherapy studies. THE repr system makes it possible to self administer drugs in the comfort of ones own home and in the time window that is convenient for the patient and the family. This is a huge cost savings advantage and convenience.

THE company's recent FDA issues are now history. They forced the company to upgrade its internal quality and documentation process. I see this as a marketing plus for a small company talking with big pharma.